Skip to content

Earnings yield at other companies

CVS Health logo
CVS HealthCVS
3.2%-3.0pp
UnitedHealth Group logo
UnitedHealth GroupUNH
4.9%+0.3pp
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
-14.3%-6.3pp
Astrana Health logo
Astrana HealthASTH
2.2%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
3.8%
Elevance Health logo
Elevance HealthELV
8.2%+2.1pp

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Calculated from Evolent Health, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s earnings yield?
Evolent Health, Inc. (EVH) reported earnings yield of -195.1% in Q1 2026.
How has Evolent Health, Inc.'s earnings yield changed year-over-year?
Evolent Health, Inc.'s earnings yield decreased by 1876.7% year-over-year, from -9.9% to -195.1%.
What is the long-term trend for Evolent Health, Inc.'s earnings yield?
Over 5 years (2020 to 2025), Evolent Health, Inc.'s earnings yield has grown at a 38.7% compound annual growth rate (CAGR), from -23.3% to -119.7%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.